Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat

J Lipid Res. 2006 Aug;47(8):1771-9. doi: 10.1194/jlr.M500528-JLR200. Epub 2006 May 9.

Abstract

We aimed to identify mechanisms by which apolipoprotein B-48 (apoB-48) could have an atherogenic role by simultaneously studying the metabolism of postprandial apoB-48 and apoB-100 lipoproteins. The kinetics of apoB-48 and apoB-100, each in four density subfractions of VLDL and intermediate density lipoprotein (IDL), were studied by stable isotope labeling in a constantly fed state with half-hourly administration of almond oil in five postmenopausal women. A non-steady-state, multicompartmental model was used. Despite a much lower production rate, VLDL and IDL apoB-48 shared a similar secretion pattern with apoB-100: both were directly secreted into all fractions with similar percentage mass distributions. Fractional catabolic rates (FCRs) of apoB-48 and apoB-100 were similar in VLDL and IDL. We identified a fast turnover compartment of light VLDL that had a residence time of <30 min for apoB-48 and apoB-100. Finally, a high secretion rate of apoB-48 was associated with a slow FCR of VLDL and IDL apoB-100. In conclusion, the intestine secretes a spectrum of apoB lipoproteins, similar to what the liver secretes, albeit with a much lower secretion rate. Once in plasma, intestinal and hepatic triglyceride-rich lipoproteins have similar rates of clearance and participate interactively in similar metabolic pathways, with high apoB-48 production inhibiting the clearance of apoB-100.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Apolipoprotein B-100
  • Apolipoprotein B-48
  • Apolipoproteins B / metabolism*
  • Body Mass Index
  • Cholesterol / metabolism
  • Deuterium
  • Dietary Fats / administration & dosage
  • Dietary Fats / pharmacokinetics*
  • Female
  • Humans
  • Intestinal Mucosa / metabolism*
  • Intestines / drug effects
  • Kinetics
  • Lipoproteins, VLDL / metabolism
  • Liver / drug effects
  • Liver / metabolism*
  • Middle Aged
  • Models, Biological

Substances

  • Apolipoprotein B-100
  • Apolipoprotein B-48
  • Apolipoproteins B
  • Dietary Fats
  • Lipoproteins, VLDL
  • Cholesterol
  • Deuterium